Genetic Deep-Dive could reshape breast cancer risk scores

NCT ID NCT07734389

Recruiting now Knowledge-focused Sponsor: Institute of Oncology Ljubljana Source: ClinicalTrials.gov ↗

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This study tests whether adding genetic assessment and verified family history to standard risk models can better classify breast cancer risk in women already considered at moderately increased or high risk. Participants receive genetic counseling and, if eligible, genetic testing. The goal is to see if some women can be reclassified to a lower risk level, potentially reducing unnecessary screening.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Comprehensive clinical and genetic breast cancer risk assessment
What this could lead to: If successful, this approach could help women avoid unnecessary worry and screening by more accurately identifying who truly has high breast cancer risk.
What could go wrong: This is a small, early-stage study focused on risk classification, not on preventing or treating cancer. The results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER BREAST CANCER RISK

Contacts and locations

Locations

Institute of Oncology Ljubljana
RECRUITING

Ljubljana, 1000, Slovenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.